Testing effectiveness (Phase 2)WithdrawnNCT05371275
What this trial is testing
Phase II Safety Single-arm Study of CDK4/6 Inhibition With Palbociclib in Hospitalized, Moderate COVID-19 Cases to Prevent Thromboinflammation
Who this might be right for
COVID-19
biotx.ai GmbH